Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimusDEL BUFALO, Donatella; CIUFFREDA, Ludovica; TRISCIUOGLIO, Daniela et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5549-5554, issn 0008-5472, 6 p.Article

Temsirolimus, an Inhibitor of Mammalian Target of RapamycinRINI, Brian I.Clinical cancer research. 2008, Vol 14, Num 5, pp 1286-1290, issn 1078-0432, 5 p.Article

mTOR Is Activated in the Majority of Malignant MelanomasKARBOWNICZEK, Magdalena; SPITTLE, Cynthia S; MORRISON, Tasha et al.Journal of investigative dermatology. 2008, Vol 128, Num 4, pp 980-987, issn 0022-202X, 8 p.Article

mtor-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. CommentaryBERNDT, Michael C; ANDREWS, Robert K; MCLNTYRE, Thomas M et al.Blood. 2007, Vol 109, Num 5, issn 0006-4971, 1791, 1975-1983 [10 p.]Article

Dysregulation of the TSC-mTOR pathway in human diseaseINOKI, Ken; CORRADETTI, Michael N; GUAN, Kun-Liang et al.Nature genetics. 2005, Vol 37, Num 1, pp 19-24, issn 1061-4036, 6 p.Article

Combination Strategy Targeting the Hypoxia Inducible Factor-1α with Mammalian Target of Rapamycin and Histone Deacetylase InhibitorsVERHEUL, Henk M. W; SALUMBIDES, Brenda; VAN ERP, Karen et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3589-3597, issn 1078-0432, 9 p.Article

PEComas : the past, the present and the futureMARTIGNONI, Guido; PEA, Maurizio; REGHELLIN, Daniela et al.Virchows Archiv. 2008, Vol 452, Num 2, pp 119-132, issn 0945-6317, 14 p.Article

Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary glandTORRES-ARZAYUS, Maria I; JING YUAN; DELLAGATTA, Jamie L et al.Cancer research (Baltimore). 2006, Vol 66, Num 23, pp 11381-11388, issn 0008-5472, 8 p.Article

Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinomaHERBERGER, Beata; PUHALLA, Harald; LEHNERT, Martina et al.Clinical cancer research. 2007, Vol 13, Num 16, pp 4795-4799, issn 1078-0432, 5 p.Article

Survival signaling by notch1 : Mammalian target of rapamycin (mTOR)-dependent inhibition of p53SATHISH KUMAR MUNGAMURI; XIAOHE YANG; THOR, Ann D et al.Cancer research (Baltimore). 2006, Vol 66, Num 9, pp 4715-4724, issn 0008-5472, 10 p.Article

mTOR inhibition and its effect on cancer in transplantationANDRASSY, Joachim; GRAEB, Christian; RENTSCH, Markus et al.Transplantation. 2005, Vol 80, Num 7, pp S171-S174, issn 0041-1337, SUPConference Paper

CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1MUROOKA, Thomas T; RAHBAR, Ramtin; PLATANIAS, Leonidas C et al.Blood. 2008, Vol 111, Num 10, pp 4892-4901, issn 0006-4971, 10 p.Article

Differential impact of mammalian target of rapamycin inhibition on CD4⁺CD25⁺Foxp3⁺ regulatory T cells compared with conventional CD4⁺ T cellsZEISER, Robert; LEVESON-GOWER, Dennis B; ZAMBRICKI, Elizabeth A et al.Blood. 2008, Vol 111, Num 1, pp 453-462, issn 0006-4971, 10 p.Article

Mammalian Target of Rapamycin Is the Key Effector of Phosphatidylinositol-3-OH-lnitiated Proliferative Signals in the Thyroid Follicular EpitheliumYEAGER, Nicole; BREWER, Charlene; CAI, Kathy Qi et al.Cancer research (Baltimore). 2008, Vol 68, Num 2, pp 444-449, issn 0008-5472, 6 p.Article

Molecular context of the EGFR mutations : Evidence for the activation of mTOR/S6K signalingCONDE, Esther; ANGULO, Barbara; MOYING TANG et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 710-717, issn 1078-0432, 8 p., 1Article

Regulation of microtubule-dependent protein transport by the TSC2/Mammalian target of rapamycin pathwayXIUYUN JIANG; YEUNG, Raymond S.Cancer research (Baltimore). 2006, Vol 66, Num 10, pp 5258-5269, issn 0008-5472, 12 p.Article

Primary Cilia Bend LKB1 and mTOR to Their WillAZNAR, Nicolas; BILLAUD, Marc.Developmental cell. 2010, Vol 19, Num 6, pp 792-794, issn 1534-5807, 3 p.Article

mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and AgingCASTILHO, Rogerio M; SQUARIZE, Cristiane H; CHODOSH, Lewis A et al.Cell stem cell. 2009, Vol 5, Num 3, pp 279-289, issn 1934-5909, 11 p.Article

Exploiting the mammalian target of rapamycin pathway in hematologic malignanciesALTMAN, Jessica K; PLATANIAS, Leonidas C.Current opinion in hematology. 2008, Vol 15, Num 2, pp 88-94, issn 1065-6251, 7 p.Article

The mammalian target of rapamycin pathway as a potential target for cancer chemopreventionKOPELOVICH, Levy; FAY, Judith R; SIGMAN, Caroline C et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 7, pp 1330-1340, issn 1055-9965, 11 p.Article

Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-κBCOSTA, Lara F; BALCELLS, Mercedes; EDELMAN, Elazer R et al.Blood. 2006, Vol 107, Num 1, pp 285-292, issn 0006-4971, 8 p.Article

La protéine suppresseur de tumeur PML bloque la néoangiogenèse en réprimant mTorLARSEN, Christian-Jacques.Bulletin du cancer. 2006, Vol 93, Num 11, pp 1085-1086, issn 0007-4551, 2 p.Article

Acute Alcohol Intoxication Increases REDD1 in Skeletal MuscleLANG, Charles H; FROST, Robert A; VARY, Thomas C et al.Alcoholism, clinical and experimental research. 2008, Vol 32, Num 5, pp 796-805, issn 0145-6008, 10 p.Article

Mammalian Target of Rapamycin and S6 Kinase 1 Positively Regulate 6-thioguanine-Induced AutophagyXUEHUO ZENG; KINSELLA, Timothy J.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2384-2390, issn 0008-5472, 7 p.Article

Page / 12